Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.

Through a structure-based molecular hybridization approach, a novel series of diarylnicotinamide derivatives (DANAs) targeting the entrance channel of HIV-1 NNRTIs binding pocket (NNIBP) were rationally designed, synthesized and evaluated for their anti-HIV activities in MT-4 cells together with the inhibition against the reverse transcriptase (RT) in an enzymatic assay. Encouragingly, most of the new DANAs were found to be active against wild-type HIV-1 with an EC50 in the range of 0.027-4.54 μM. Among them, compound 6b11 (EC50 = 0.027 μM, SI > 12518) and 6b5 (EC50 = 0.029 μM, SI = 2471) were identified as the most potent inhibitors, which were more potent than the reference drugs nevirapine (EC50 = 0.31 μM) and delavirdine (EC50 = 0.66 μM). Some DANAs were also active at micromolar concentrations against the K103N + Y181C resistant mutant. Compound 6b11 exhibited the highest enzymatic inhibition activity (IC50 = 20 nM), which is equal to that of efavirenz (EC50 = 20 nM) and 31 times higher than that of nevirapine (EC50 = 0.62 μM). Preliminary structure-activity relationships (SARs) and molecular modeling of these new DANAs have been discussed.

[1]  A. Bergamini,et al.  Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity. , 2007, Journal of medicinal chemistry.

[2]  E. De Clercq,et al.  Recent advances in DAPYs and related analogues as HIV-1 NNRTIs. , 2011, Current medicinal chemistry.

[3]  Peng Zhan,et al.  HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design , 2013, Medicinal research reviews.

[4]  W. Greenlee,et al.  5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. , 1993, Journal of medicinal chemistry.

[5]  P. Fernandes,et al.  The current status of the NNRTI family of antiretrovirals used in the HAART regime against HIV infection. , 2008, Current medicinal chemistry.

[6]  J Desmyter,et al.  Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. , 1988, Journal of virological methods.

[7]  E. De Clercq,et al.  Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors. , 2011, European journal of medicinal chemistry.

[8]  Peng Zhan,et al.  Design strategies of novel NNRTIs to overcome drug resistance. , 2009, Current medicinal chemistry.

[9]  R. Steigbigel,et al.  Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase. , 1993, Journal of virological methods.

[10]  F. Brun-Vézinet,et al.  Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.

[11]  A. Bergamini,et al.  Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. , 2006, Journal of medicinal chemistry.

[12]  Xiaohong Liu,et al.  Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design. , 2010, Journal of medicinal chemistry.

[13]  P. Fernandes,et al.  The Current Status of the NNRTI Family of Antiretrovirals Used Against HIV Infection , 2008 .

[14]  Zengjun Fang,et al.  Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies. , 2009, Bioorganic & Medicinal Chemistry.

[15]  E. Novellino,et al.  Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus. , 2009, Journal of medicinal chemistry.

[16]  E. Novellino,et al.  Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. , 2011, Journal of medicinal chemistry.

[17]  Peng Zhan,et al.  Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms. , 2012, Journal of medicinal chemistry.

[18]  E. De Clercq,et al.  Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[19]  Mati Karelson,et al.  of Molecular Design , 2002 .

[20]  Peng Zhan,et al.  Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach. , 2014, European journal of medicinal chemistry.

[21]  E. Novellino,et al.  New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2014, European journal of medicinal chemistry.

[22]  A. Coluccia,et al.  Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives. , 2005, Journal of medicinal chemistry.

[23]  Jim Euchner.  Design , 2014, Catalysis from A to Z.

[24]  J. Levin,et al.  An Alternative Procedure for the Aluminum-Mediated Conversion of Esters to Amides , 1983 .

[25]  W. Greenlee,et al.  5‐Chloro‐3‐(phenylsulfonyl)indole‐2‐carboxamide: A Novel, Non‐ Nucleoside Inhibitor of HIV‐1 Reverse Transcriptase. , 1994 .

[26]  G. McGaughey,et al.  Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). , 2008, Bioorganic & medicinal chemistry letters.

[27]  T. A. Hagan,et al.  Detection , Isolation , and Continuous Production of Cytopathic Retroviruses ( HTLV-III ) from Patients with AIDS and Pre-AIDS , 2022 .

[28]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[29]  E. Novellino,et al.  New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2012, Journal of medicinal chemistry.

[30]  Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2013, European journal of medicinal chemistry.

[31]  C. Pannecouque,et al.  Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later , 2008, Nature Protocols.